1. Home
  2. BODI vs RNTX Comparison

BODI vs RNTX Comparison

Compare BODI & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

HOLD

Current Price

$10.13

Market Cap

75.4M

Sector

Industrials

ML Signal

HOLD

Logo Rein Therapeutics Inc.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.03

Market Cap

89.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BODI
RNTX
Founded
1998
2001
Country
United States
United States
Employees
270
10
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.4M
89.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BODI
RNTX
Price
$10.13
$1.03
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$15.00
$10.00
AVG Volume (30 Days)
25.8K
640.3K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.76
$0.85
52 Week High
$16.87
$2.18

Technical Indicators

Market Signals
Indicator
BODI
RNTX
Relative Strength Index (RSI) 49.94 52.20
Support Level $9.42 $0.99
Resistance Level $11.11 $1.32
Average True Range (ATR) 0.75 0.08
MACD 0.23 0.02
Stochastic Oscillator 69.52 92.31

Price Performance

Historical Comparison
BODI
RNTX

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Share on Social Networks: